This site is intended for healthcare professionals residing in Canada.

Visit Pfizer AcademySearch

Menu

Close

Sign InLog Out
  • EN
ProductsTherapy AreasExplore ContentExplore
ContentGo to Explore ContentEventsMaterialsVideosPatient SupportContact
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Français

Menu

Close

About Prevnar 13About Prevnar 13Mechanism of ActionSerotype coverageIncidence of IPD and Colonization dataExperienceImmunogenicityDosingDosingDosingEfficacy and Safety ProfileEfficacy and Safety ProfileEfficacy profileSafety profileGuidelinesGuidelinesGuidelinesResourcesResourcesMaterialsVideos
Product MonographImportant Safety Information 
Prevnar 1312+ years of experience in Canadian children1,2*>125 countries include Prevnar 13 on their national immunization programs3* Built on a foundation of clinical research,* including:1

9 randomized controlled trials designed to demonstrate the immunogenicity and safety profile of Prevnar 13 in a 3- or 4-dose immunization series.1*

Over 6,000 infants and children aged 6 weeks to 5 years included in clinical trials.1* 

Thanks to healthcare professionals like you, Canadian babies can receive recommended pneumococcal immunization that helps protect against IPD and AOM.

AOM: acute otitis media; IPD: invasive pneumococcal disease.* Clinical significance unknown.References:Prevnar® 13 Product Monograph. Pfizer Canada ULC. 2022.Health Canada. Prevnar 13 Summary Basis of Decision. Data on File. Pfizer Canada ULC. 2019.
About Prevnar 13
NEXT

Immunogenicity data

 Visit page Loading
Learn more about

Dosing

 Visit page Loading
PP-PRV-CAN-0016-EN

To report an adverse event, please call 1-866-723-7111

PfizerPro AccountPfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign in or RegisterSign inRegisterAccountSign Out

© Pfizer Canada ULC 2024. All rights reserved. The information is intended only for healthcare professionals resident in Canada. ®Pfizer Inc., used under license.

PP-UNP-CAN-0145-EN
You are now leaving Pfizerpro.ca website
Links to other sites are provided as a convenience to the viewer, and should not be taken as an endorsement of the sites or an association with their owners. Pfizer Canada accepts no responsibility for the content of linked sites.
You are now leaving the PfizerPro Portal.
You are about to view resources made available by Pfizer Academy. 
These resources include learning programs and upcoming events. By selecting Go to link below, you acknowledge and certify that you are a Canadian Healthcare Professional.
PP-UNP-CAN-0013 EN